A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

Bone Marrow Transplantation

Volumn 27, Issue 4, 2001, Pages 433-436

  Endo, T ^a   Sakai, T ^a   Fujimoto, K ^a   Yamamoto, S ^a   Takashima, H ^a   Haseyama, Y ^a   Nishio, M ^a   Koizumi, K ^a   Koike, T ^a   Sawada, K ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Hepatitis B; Lamivudine; Non Hodgkin's lymphoma; Peripheral blood stem cell transplantation (PBSCT)

Indexed keywords

ALPHA INTERFERON; CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DNA POLYMERASE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LAMIVUDINE; NUCLEOSIDE ANALOG; PREDNISOLONE; RANIMUSTINE; VINCRISTINE; VIRUS DNA;

ACUTE HEPATITIS; ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; DRUG MEGADOSE; FATALITY; HEMATOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE DEFICIENCY; JAPAN; MALE; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; VIRUS CARRIER; VIRUS INHIBITION; VIRUS REACTIVATION;

ADULT; ANTINEOPLASTIC AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LYMPHOMA, NON-HODGKIN; MALE; REVERSE TRANSCRIPTASE INHIBITORS; TRANSPLANTATION, AUTOLOGOUS; VIRUS ACTIVATION;

EID: 17744371432     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702804     Document Type: Article

References (25)

1. A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma
2. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B
3. Hepatitis B infection in patients with lymphoma
4. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
5. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies
6. Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan
7. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: A case controlled study
8. A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection
9. A preliminary trial of lamivudine for chronic hepatitis B infection
10. Prevention of hepatitis B flare-up during chemotherapy using lamivudine: Case report and review of the literature
11. Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation
12. DNA polymerase associated with human hepatitis B antigen
13. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay
14. 1764) of hepatitis B virus: Clinical significance and an easy method for detection
15. Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphomas: A pilot study for a leukocyte count oriented regimen
16. Prevention of severe hepatic injury by interferon-α in chronic active hepatitis lacking HBeAg (mutant strain) in a patient with malignant lymphoma
17. Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following standard-dose combination chemotherapy with etoposide, ifosfamide, and cisplatin
18. Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis
19. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis
20. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumors
21. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies
22. Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma
23. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
24. An open comparative study of lamivudine and famciclovir in the treatment of chronic hepatitis B infection
25. Hepatitis B reactivation after lamivudine